 OncLive | First-Line Dose-Dense Induction and High-Dose Chemotherapy/Autologous ... OncLive First-Line Dose-Dense Induction and High-Dose Chemotherapy/Autologous Stem Cell Transplant Benefits Patients With Rare Lymphomas. Jill Stein. Published Online: Monday, October 8, 2012 [ Request Print ]. Print. Email. Dr. Francesco d'Amore. Francesco ... |
